Assessment of Reticulocyte and Erythrocyte Parameters From Automated Blood Counts in Vaso-Occlusive Crisis on Sickle Cell Disease.
erythrocyte parameters
immature reticulocyte fraction
reticulocyte count
sickle cell disease
vaso-occlusive crisis
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
01
2022
accepted:
21
03
2022
entrez:
2
5
2022
pubmed:
3
5
2022
medline:
3
5
2022
Statut:
epublish
Résumé
Sickle cell disease is a complex genetic disease involving cell adhesion between red blood cells, white blood cells, platelets and endothelial cells, inducing painful vaso-occlusive crisis (VOC). We assessed reticulocyte and erythrocyte parameters in a cohort of confirmed SCD patients, and investigated whether a combination of these routine laboratory biomarkers of haemolysis could be used to predict VOC development. Reticulocyte and erythrocyte parameters were evaluated using the Sysmex XN-9000 analyser. A total of 98 patients with SCD were included, 72 in steady state and 26 in VOC. Among the 72 patients in steady state, 22 developed a VOC in the following year (median: 3 months [2-6]). The following parameters were increased in SCD patients with VOC development compared to SCD patients without VOC development in the following year: reticulocyte count (94.6 10
Identifiants
pubmed: 35492334
doi: 10.3389/fmed.2022.858911
pmc: PMC9044919
doi:
Types de publication
Journal Article
Langues
eng
Pagination
858911Informations de copyright
Copyright © 2022 Feugray, Kasonga, Grall, Benhamou, Bobée-Schneider, Buchonnet, Daliphard, Le Cam Duchez, Lahary and Billoir.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cytokine. 2021 Jul;143:155534
pubmed: 33888402
Curr Med Res Opin. 2021 May;37(5):761-768
pubmed: 33686891
Br J Haematol. 2016 Oct;175(1):141-53
pubmed: 27378309
Blood. 2006 Mar 15;107(6):2279-85
pubmed: 16291595
Paediatr Int Child Health. 2018 Nov;38(4):244-250
pubmed: 30295174
Int J Lab Hematol. 2020 Apr;42(2):e88-e91
pubmed: 31756027
N Engl J Med. 2017 Apr 20;376(16):1561-1573
pubmed: 28423290
Am J Hematol. 2021 Jan;96(1):9-11
pubmed: 33108017
N Engl J Med. 2017 Feb 2;376(5):429-439
pubmed: 27959701
EBioMedicine. 2016 Aug;10:305-11
pubmed: 27412264
Lancet. 2010 Dec 11;376(9757):2018-31
pubmed: 21131035
Ann Hematol. 2022 Jan;101(1):35-41
pubmed: 34564750
Haematologica. 2008 Jan;93(1):20-6
pubmed: 18166781
Tissue Cell. 2021 Aug;71:101578
pubmed: 34130070
BMC Hematol. 2017 Sep 15;17:15
pubmed: 28932402
J Biomech. 2017 Jan 4;50:34-41
pubmed: 27876368
Br J Haematol. 2013 Apr;161(2):270-8
pubmed: 23406172
Blood. 2001 Sep 15;98(6):1955-62
pubmed: 11535535
PLoS One. 2020 Jan 29;15(1):e0228399
pubmed: 31995624
Clin Chim Acta. 2019 Jun;493:129-137
pubmed: 30825426
Clin Chem Lab Med. 2013 Aug;51(8):1595-603
pubmed: 23492565
N Engl J Med. 2019 Aug 8;381(6):509-519
pubmed: 31199090
Br J Haematol. 2021 Aug;194(4):767-778
pubmed: 34268729
Br J Haematol. 2005 May;129(4):465-81
pubmed: 15877729
Expert Rev Hematol. 2021 Mar;14(3):281-292
pubmed: 33543663
Int J Lab Hematol. 2020 Dec;42(6):697-704
pubmed: 32639680
Am J Hematol. 2021 Nov 1;96(11):1505-1517
pubmed: 34331722
Haematologica. 2020 Aug 13;105(10):2368-2379
pubmed: 33054077
Clin Lab Med. 2015 Mar;35(1):133-63
pubmed: 25676377
Ann Hematol. 2011 Jul;90(7):759-68
pubmed: 21181161
Int J Lab Hematol. 2017 Feb;39(1):32-41
pubmed: 27566136
Exp Biol Med (Maywood). 2016 Apr;241(7):689-96
pubmed: 26936084